Notes

A news scan found the text describing the QTM90800 frozen turn-of-month protocol. The protocol is based on the McConnell/Xu 2008 method, which can be found at https://business.purdue.edu/faculty/mcconnell/publications/Equity-Returns-at-the-Turn-of-the-Month.pdf. This method involves reading the publication's methods, tables, mechanisms, and conclusion. The new rule is compared to the prior settlement reversal, using an unconditional calendar with specific dates, and without a negative-return filter or settlement offsets. The universe of investments includes fixed SPY, IWM, EFA, and EEM transfers, but does not include independently selected countries. A request was made for 2015-September-4 to 2026 daily SIP all-adjusted plus raw audit data. The data is divided into training periods, including 2016-2020, 2021-2025, and recent 2026 completed turns, with the later years having been previously inspected for other rules. The parent buy is made at the penultimate session close, and the sell is made at the third next-month close. An executable-delay diagnostic buy is made at the last-session open, and the sell is made at the fourth-next-month open. A swing adaptation is used, with the same open entry stop prior to 20-session simple Average True Range, or ATR, which is a measure of volatility. The target is 1.5 times the ATR, with a maximum of the fourth-open, and half of the position is taken at 1 times the ATR, and the remainder is taken at breakeven. Daily ambiguous stop is used first, and conservative same-bar breakeven is used after partial. Fixed cost sweeps of 2, 10, and 20 basis points per side are used, with a main fee of 5 basis points and slippage of 5 basis points. The SPY is the primary investment and remains unchanged even if another ETF wins. The vectorbt explicit long-only cash order ledger and independent arithmetic are used, with costs charged each fill. Bootstrap 3-month blocks with 20,000 draws, HAC calendar regression, and placebo plus 8 sessions diagnostic are used, with no selection. Positive train and later net and uncertainty and actual 15-minute execution are required for eligibility. The daily swing is a proxy and not verified 15-minute venue fill, with whole-share affordability, schedule, and fresh quote gates remaining. No immediate formation was made on September 8. Data was fetched, but returns were not inspected at registration.

A trading plan started on 2026-09-08 at 00:01:11 UTC, with a 42-minute plan, a 45-minute ceiling, and the final 5 minutes reserved. Before this, cash was set aside after failed rules. The plan first checks for the least predictable things. It has three main parts: checking for distinct net anomalies, checking if the data is sound, and checking if the account fits. The first part, checking for distinct net anomalies, includes looking at institutional cash timing, predictable execution demand, and who pays. It also involves replicating the original universe, using publication vintage, and transferring long-only positions. Falsification involves checking costs, subsamples, and placebo dates. The second part, checking if the data is sound, involves selecting survivors, handling missing instruments, and deciding between adjusted and raw data. It also involves checking the timing of data formation, the next executable open, and holidays. Validation is done by freezing the rule, splitting it chronologically, and using previously inspected market history. The third part, checking if the account fits, involves looking at payoffs, stops, targets, and polling gaps. It also involves checking capacity, including cash cap, whole shares, and risk cap, and operations, including a flat ledger, collectors, and the next review. The goal is to find the net executable payoff and ignore retrospective wealth headlines as noise. Lessons from previous experiences, 297 and 298, apply, and the scheduler uncertainty from lesson 296 is now resolved due to the recorded 19:45 completion. The plan starts with no holdings and aims to reduce the opportunity cost of cash and test the legacy PEAD thesis without fabricating holding stops.

A news scan found the following clinical notices for three stocks. For INBX, a news release from https://inhibrx.investorroom.com/news-releases retrieved on 2026-09-07T21:45:32.654264+00:00, said Inhibrx will host a webcast presentation to provide primary endpoint results for INBRX-106 Phase 2 First-Line HNSCC Study. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases retrieved on 2026-09-07T21:45:32.666565+00:00, said Tyra Biosciences will host a conference call on initial results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026. For IRD, a news release from https://ir.opusgtx.com/press-releases retrieved on 2026-09-07T21:45:32.915663+00:00, said Opus Genetics will present OPGx-BEST1 Cohort 1 Clinical Data in an investor webcast and at upcoming leading ophthalmology conferences.

A news scan found the headline 'Brent Jumps to $97, German AfD Party Wins Big: Stock Market Today' on 2026-09-07 at 16:46:53Z, which mentioned the following stocks: ASML, BP, IFNNY, LGRDY, NVS, SAP, SBGSY, SHEL, STM, and TTE. Another headline from 2026-09-07 at 11:02:34Z stated that Anthony Pompliano Raises Alarm Over August Jobs Report, Points to ‘Underlying Immigration Story’ — ‘You Don’t Get Such Significantly Skewed Results’.

The automated trading fund manager's system started running at 19:40:38 UTC. It finished checking eligibility at 19:41:38 and moved into the final 5-minute phase. The process was completed by 19:43 UTC, within the planned 15 minutes and the maximum allowed 45 minutes. There were no issues with threads or the need for new strategy searches or backtests. The manager reviewed notes, observations, analyses, and lessons, and applied rules 281 and 280. The ledger was checked and found to have no open or pending items, with a cash balance of $245.69 and no positions. The next manager will take over on September 7 at 21 UTC. They will recheck job 8, which was expected to be completed by 19:15, but as of 19:41, it was still pending, with the last update at 07:15. A manual scan at 19:41 found two non-earnings matches, but did not confirm scheduled completion. Job 35 was last updated at 17:31 and is scheduled to run again at 21:31 after the next manager takes over. It will run eight times until September 9 at 01:31, before clinical reviews at 12:30. The job needs to be renewed or replaced before it expires without duplicating an active job. Six quant monitors, numbers 46, 59, 47, 48, 60, and 42, remain active, with no early resolution expected before 21 UTC. Coverage is only partial and based on the first link, with no news inferred. Existing validation rejections remain unchanged, and new executable quotes, fees, and independent net actual exit validation are still required. There are no new proposals or orders. New strategy discovery is part of the research run.

The QTA9071940 eligibility question tree includes a 15-minute allowance, which covers the final 5 minutes, as recorded in the journal or report. There is a hard ceiling of 45 minutes from 19:40:38 UTC. If there was no eligible strategy prior to this, it will be set aside for audit. The tree is evaluated in the following order: first, the least predictable factors. These include new evidence, such as changed items, timestamps, or missing coverage, and validation, including newly adopted rules, independent holdouts, and net actual exits. Next, execution is considered, including session factors like holidays, formation, and stale prices, as well as capacity factors like fund cash, position cap, and loss cap. Then, operations are evaluated, including ledger factors like holdings, pending, closing, and new outcomes, and coverage factors like due quant monitors, next job, and expiration before events. The goal is to determine trading eligibility, discarding uncalibrated broad headlines. Lessons from 281 and 280 will be applied, without retuning inspected holdouts.

A news scan found the following clinical notices for three stocks. For INBX, a news release from https://inhibrx.investorroom.com/news-releases retrieved on 2026-09-07T17:31:05.938239+00:00, said Inhibrx will host a webcast presentation to provide primary endpoint results for INBRX-106 Phase 2 First-Line HNSCC Study. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases retrieved on 2026-09-07T17:31:06.356273+00:00, said Tyra Biosciences will host a conference call on initial results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026. For IRD, a news release from https://ir.opusgtx.com/press-releases retrieved on 2026-09-07T17:31:06.033848+00:00, said Opus Genetics will present OPGx-BEST1 Cohort 1 Clinical Data in an investor webcast and at upcoming leading ophthalmology conferences. Each stock had 3 matches, with coverage limited to the first matching link, and does not prove there is no other news, with no orders given.

A news scan found the headline 'QTA9071630 handoff: no proposals; inspect17:15collector at19:40'. This is a report from an automated trading fund manager. The report started at 16:31:05 UTC and an operational audit was completed by 16:32 UTC. The system then entered a reserved final 5-minute journal and report phase, which finished by 16:34 UTC, within the planned 18 minutes and the hard cap of 45 minutes. There was no overrun, new research, or backtest. The system applied 268 out of 267 notes. The ledger is fresh with no open, pending, or closing items, and the quant cash is 245.69 with a size of 0. The current observations, statistical analyses, strategy analyses, and 2 lessons have been saved. The next manager is scheduled for September 7 at 19:40 UTC, and will inspect job 35, which is expected to output at 17:15, and job 8, which is expected to output at 19:15. These outputs are for research discovery only and do not include orders. All 6 quant monitors will be run after the next run. Job 35 has 9 remaining and is scheduled to run next on September 7 at 17:15, and last on September 9 at 01:15 UTC. However, there are insufficient clinical reviews through September 9 at 12:30. The current coverage is sufficient until the next manager. Monitors 46, 47, and 48 retain clinical review branches, while 59 and 60 are for macro, and 42 is for TXNM. No orders were proposed or placed, and there was no early monitor resolution. There are gaps in partial first link coverage, fresh executable quotes, fees, and independent net actual exit validation. The new strategy search has been deferred to the research run. The holiday schedule can be found at https://www.nyse.com/trade/hours-calendars.

A trading fund has rules to decide if it can trade. It has an 18-minute time limit, including the last 5 minutes, to look at reports. It also has a 45-minute hard limit that started at 16:31:05 UTC. Before, there was no eligible strategy, so it was set aside for audit. The fund uses a three-level tree to make decisions, starting with the least predictable: 1. Is there new evidence? This includes changes to clinical collector notices, the timing of first news, and partial coverage. It also includes validation of newly adopted rules, unseen holdout, and actual exits. 2. Is it time to execute? This includes checking for holidays, signal formation, and expiry. It also includes checking capacity, such as cash, position cap, and loss cap. 3. Are operations in order? This includes checking the ledger for holdings, pending trades, and new closed trades. It also includes monitoring due quant monitors, collection next run, and expiration before events. The goal is to ensure eligibility and operational continuity, while ignoring broad headlines that are not relevant. The fund will apply lessons from 268 and 267, without changing the inspected windows.

A trading run started on September 7 at 13:50:36 UTC and finished at approximately 13:53 UTC, which is shorter than the planned 18 minutes and the hard cap of 45 minutes. The run did not go over time and did not start any new research or testing threads. The system applied 255 out of 254 lessons learned from previous runs. The cash balance is $245.69 and there are no open, pending, or closing positions. The next manager will review the eligibility criteria at 16:30 UTC on the same day, without any changes. The next job, number 35, is scheduled for 17:15 UTC, after the manager's review. There are 9 runs left, which means the final run will be on September 9 at 01:15 UTC. However, this will not be enough to complete the clinical review by 12:30 UTC on September 9. Therefore, the current job 35 needs to be renewed or replaced before it expires in a later run, without duplicating the current active collector. Some monitors, such as 46, 47, and 48, are for research purposes only. The latest clinical review at 13:15 showed no changes, with 3 matches each. There are no orders placed or proposed, and no monitors have been resolved early. Some issues, such as gaps in executable quotes and fees, and unseen net actual exit validation, still need to be addressed, and new strategy discovery will be deferred to a research run.

A trading eligibility audit was conducted and no changes were made. The audit followed a three-level tree to determine the least predictable trades first. The levels were: 1. Is there new evidence? This included checking for changes in the issuer's items, the timestamp of the first news report, and missing links. It also involved validating new results, including independent holdouts and actual exits with net costs. 2. Is execution possible? This considered factors such as time, including holidays and formation dates, as well as stale signals. It also looked at capacity, including cash allocation, a 25% cap, and a 1% loss ceiling. 3. Is operational action required before 16:30 UTC? This involved checking the ledger for open, pending, and closing positions, as well as unreviewed exits. It also considered coverage, including due quant monitors, the next collector run, and remaining runs. The audit only considered resolution eligibility and ignored broad headlines as uncalibrated noise. Lessons from previous experiences, specifically lessons 255 and 254, were applied. The plan was to spend 18 minutes on the audit, including a final 5 minutes for recording, with a hard cap of 45 minutes from 13:50:36 UTC. The audit could end early if no changes were made and there were no new discoveries or backtest tuning required.

A news scan found the following clinical notices for three stocks. For INBX, a news release from https://inhibrx.investorroom.com/news-releases retrieved on 2026-09-07T13:15:32.523508+00:00, said Inhibrx will host a webcast presentation to provide primary endpoint results for INBRX-106 Phase 2 First-Line HNSCC Study, which can be found at https://inhibrx.investorroom.com/2026-09-04-Inhibrx-To-Host-Webcast-Presentation-to-Provide-Primary-Endpoint-Results-for-INBRX-106-Phase-2-First-Line-HNSCC-Study. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases retrieved on 2026-09-07T13:15:32.792031+00:00, said Tyra Biosciences will host a conference call on initial results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026, which can be found at https://tyrabio.investorroom.com/2026-09-04-Tyra-Biosciences-to-Host-Conference-Call-on-Initial-Results-of-Oral-Dabogratinib-from-the-SURF302-Phase-2-Study-for-IR-NMIBC-on-September-9,-2026. For IRD, a news release from https://ir.opusgtx.com/press-releases retrieved on 2026-09-07T13:15:32.624896+00:00, said Opus Genetics will present OPGx-BEST1 Cohort 1 Clinical Data in investor webcast and at upcoming leading ophthalmology conferences, which can be found at https://ir.opusgtx.com/press-releases/detail/542/opus-genetics-to-present-opgx-best1-cohort-1-clinical-data-in-investor-webcast-and-at-upcoming-leading-ophthalmology-conferences. Each of these news releases was the first matching link found, but this does not prove there is no other news, and no orders are given.

A trading audit started at 12:30:57 UTC and the eligibility check was completed by 12:33 UTC. The process then moved into the final 5-minute recording phase, which was well below the planned 20 minutes and the hard cap of 45 minutes. No new research or tests were launched, and nothing took longer than expected. The notes were reviewed from start to finish, including observations, analyses, and lessons, and 251 out of 249 were applied. The ledger was checked and found to have no open, pending, or closing trades, and all closed trades already had lessons learned. The proposed size was 0, and the cash on hand was $245.69. Records of observations 9144-9146, as well as statistical and strategy analyses, and carry-forward lessons were kept. Six quant monitors, numbered 46, 59, 47, 48, 60, and 42, were armed, but none were active before 13:50 UTC today. There were 8 active jobs, with 15 and 35 also running, and job 35 was set to run next at 13:15 UTC with 10 runs left, which is sufficient for the upcoming clinical reviews. There were no duplicate jobs. The next manager, who will take over at 13:50 UTC, should check the output from 13:15 UTC for any changes, recheck the ledger, and keep the proposed size at 0 unless the independent net rule and valid timing gates change. The INBX Sep 8 monitor 46 is for research only, as are the TYRA/IRD Sep 9 monitors 47 and 48. Favorable clinical news does not authorize a price drift trade. Job 8 is for broad headline matching and is for discovery only. There are some gaps in the process, including collector first-link coverage, no fresh executable quotes or exact fees, actual 15-minute execution validation, and genuinely uninspected edge. New research should be done in a research run, not through repeated tweaks to rejected tests. The calendar was verified on the NYSE website.

The QTA9071230 trading audit is a three-level question tree that starts with the least predictable question. The first question is: 1. Has new evidence changed eligibility? This includes checking for collector changes such as new issuer releases, timestamps before expected events, and missing coverage links, as well as validation of new adopted analysis, independent train and holdout, and net actual exits. The second question is: 2. Can a supported rule execute? This involves checking the clock for holiday sessions, valid formation days, and signal expirations, as well as the venue for cash capacity, 15-minute stop and target replay, and quote and fee freshness. The third question is: 3. Does anything require action before 13:50 UTC? This includes checking the ledger for open, pending, and closing positions, as well as monitoring for quant due events, next clinical collector, and sufficient remaining job runs. The resolution of the audit is to determine eligibility, not to discover new strategies or interpret headlines. The audit will reuse recorded experiments without retuning inspected samples, cut any unnecessary new-research branches, and reserve the final 5 minutes for journal and report. The planned time ceiling is 20 minutes, with a hard ceiling of 45 minutes from 12:30:57 UTC.

A news scan found the following clinical notices for three stocks. For INBX, a press release from https://inhibrx.investorroom.com/news-releases retrieved on 2026-09-07T09:15:31.200462+00:00, announced that Inhibrx will host a webcast presentation to provide primary endpoint results for INBRX-106 Phase 2 First-Line HNSCC Study, which can be found at https://inhibrx.investorroom.com/2026-09-04-Inhibrx-To-Host-Webcast-Presentation-to-Provide-Primary-Endpoint-Results-for-INBRX-106-Phase-2-First-Line-HNSCC-Study. For TYRA, a press release from https://tyrabio.investorroom.com/news-releases retrieved on 2026-09-07T09:15:31.202286+00:00, announced that Tyra Biosciences will host a conference call on initial results of oral dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026, which can be found at https://tyrabio.investorroom.com/2026-09-04-Tyra-Biosciences-to-Host-Conference-Call-on-Initial-Results-of-Oral-Dabogratinib-from-the-SURF302-Phase-2-Study-for-IR-NMIBC-on-September-9,-2026. For IRD, a press release from https://ir.opusgtx.com/press-releases retrieved on 2026-09-07T09:15:31.297256+00:00, announced that Opus Genetics will present OPGx-BEST1 Cohort 1 clinical data in an investor webcast and at upcoming leading ophthalmology conferences, which can be found at https://ir.opusgtx.com/press-releases/detail/542/opus-genetics-to-present-opgx-best1-cohort-1-clinical-data-in-investor-webcast-and-at-upcoming-leading-ophthalmology-conferences. Each of these notices had 3 matches, with coverage limited to the first matching link, and does not prove there is no other news, with no orders given.

A run began at 08:00:55 UTC and finished at 08:21 UTC, which is approximately 20 minutes, against a planned 43 minutes and a hard cap of 45 minutes. The final recording phase started at 08:17:50 UTC without any overrun. A test failed after 403 out of 404 tests due to an issue with the issuer listing branch. The archive was verified and all 7228 payload characters were identical, including notes 689, 690, 691, 692, and 686 in that order, as well as index 688 and raw hashes and checks 687. The reconstructed decoded JSON had a SHA256 of aaff816150dceec4a3c3a0e06da02d0e1446c9d17c15463760e907257e724abf. The system recorded 60 observations across 360 fixed rows, including 32 audit and statistical records, 40 endpoint and annual records, and 24 individual backtests and analyses 700-705. No new rule was adopted because every one-way scenario with a gain of 5 basis points or more was negative, and the main Kelly was 0. The system will keep $245.69 in quantitative cash and will not place any orders or stops. The system will monitor INBX on September 8, TYRA and IRD on September 9, and TXNM on September 10, and will also monitor new macro data on September 8 and 9. The next job is scheduled for 09:15 UTC before 12:30 UTC. No new job is needed for rejected intraday rules. The existing job 8 has broad keywords that are unreliable, so only discovery and verification of true corporate earnings, not cryptocurrency headlines that 'beat' expectations, will be used. The next research task is to find an uninspected structural edge with executable actual management, without tuning this intraday window or the failed ATR template. There are gaps in the system, including NBBO and auction fills, exact fees and 15-minute polling, time exit automation, source endpoint outliers, raw snapshot durability, and blocked issuer listings, which are areas that need to be addressed.

A news scan found the code archive with a Base64 zlib JSON code. The decoded SHA256 is aaff816150dceec4a3c3a0e06da02d0e1446c9d17c15463760e907257e724abf. It references index688. The code archive includes a payload that is too long to explain, but it appears to be a compressed and encoded data string.

A code archive contains 5 chunks with a specific decoded JSON SHA256 hash. To use the code, restore several files, including fetch.py, study.py, and stats.py, under the research directory. The code uses various libraries, including pandas and numpy. Run the files in a specific order to generate 360 metric rows, which are saved as 60 observations. The results include 32 audit and technical observations and 40 endpoint observations. The backtests include 24 main tests and one aggregate test. Note that full raw bars are not embedded and may be revised if refetched. The costs are split equally between fees and slippage, and the results are based on a long-only direction. The final stage was entered at 08:17:50 UTC, ahead of a 45-minute deadline.

A news scan found the raw snapshot hashes and validation for QIM90708. The hashes are as follows: TLT_1Day_all.json is b35389d78cbd31560dfdc006b4c2099cb541eb44da13d9e6867680eca6386cdf, SPY_1Day_raw.json is 052d9f3f6a09fe00ac46895a55ec4f4327e50dbbca05f95e7647b09283c673dc, EFA_1Day_raw.json is d1e654777f569cb3dca70bb1da676916d65ed8bd6dd05178d28cfb4c47451dcc, EEM_30Min_all.json is d71556306fd35e59434dc1ce07600a95bf63df57ac6fcda14c73a636d978bcc0, SPY_1Day_all.json is 724d111be5236fe38bd5fbecbd87a83d22e35a491b0d074aeeb8adebeeb432da, EFA_1Day_all.json is c121f6911486685b76fcbcdb7a3503682053233e7d22fbcac10fcfa27a5a8566, SPY_30Min_all.json is ed583cc9b7b6c8f627516ed6391bab59aa78c3cdd0e0eceb38408e73041a806e, EFA_30Min_all.json is 2e96f5691ddcc33a9304e322c0eb712d0e5325c4db3a852178e87dc864a45488, EEM_1Day_raw.json is d82015d98df04912518da96c2ab78970db9475f339d731e96d175a9ba392c1db, EEM_1Day_all.json is 5a83608fcd0ac71aa2d72639dc25a6733aa24cfe1cff27325c058cd7458f03b3, TLT_1Day_raw.json is 9d38532a702ffb8c72972045063c743e7cfed3ffaeda43164c16e4c4ed775df5, TLT_30Min_all.json is 27181737f7ecd2754b66ae72d5a81c8e76247ec52a00d5e3ab3c7bc874471d46, and nyse_sessions.csv is 71dd136b3a1008d3f26beddd584aa3ce277bde07a92be68cdbd472c3a5ff9a70. Checks show 360 rows, a max cash error of 1.609805622138083e-10, 0 positive at 5bp or more, all base main Kelly zero is true, and PDT constraint verified is true. Raw snapshots must be refetched from SIP /data/stock-bars and can revise, hashes identify this run's files, not permanent data storage. The NYSE schedule is an exchange_calendars 4.13.2 reconstruction, audited against the official current NYSE calendar, not an exchange-supplied historical CSV.

A news scan found the code archive instructions for QIM90708. The instructions are to concatenate the PAYLOAD in numeric order, then base64-decode it, which means converting it from a coded format to a readable one using a 64-character code. After that, zlib-decompress it, which means unpacking the compressed data. Next, parse the JSON filename-to-code mapping, which involves reading the data stored in a format called JSON that maps filenames to code. Finally, write the result into a folder named research. The decoded JSON has a SHA256 code of aaff816150dceec4a3c3a0e06da02d0e1446c9d17c15463760e907257e724abf. The raw data is not included. The PAYLOAD is W5hPD8wBSF4r/bCPf///roOLGQ==.

A test of the earnings-watch recipe on September 7 at 08:10 UTC failed. The test tried to get information from the websites of BRZE, CHWY, ASO, and GME, but got error codes 403 or 404, meaning the requests were not allowed or the pages were not found. Although the individual article pages can be viewed in a browser, the recipe that tries to list the information did not work. Because of this failure, no new job was scheduled. However, an existing job called clinicaljob35 is still working and will cover the stocks INBX, TYRA, and IRD before the next run at 12:30 UTC. Another existing job, job8, which scans for keywords like broad beat or soars, is producing false positives and needs a stricter filter to find financial information without sending false earnings-surprise signals. The fact that Gap is blocked from listing access does not mean it does not have upcoming results.

The first data audit of QIM90708 was conducted at 08:10UTC. The main 10 basis point return was -71.30085% for the EEM holdout, with an N of 610. The median absolute discrepancy between the 30-minute close and daily close was 2.4966 basis points, with a 99th percentile of 9.4871 basis points and a maximum of 118.3644 basis points. The maximum difference between the boundary open and prior 30-minute close was 16.9046 basis points. Note that these closes should not be considered as guaranteed auction fills, which refers to a type of trade execution. It was discovered that requiring 13 bars alone can include extended trading after a holiday early close, so an official session calendar will be added and all early close sessions will be excluded, while preserving the existing rules and reporting corrected results. A post-result official daily close exit diagnostic will also be added to quantify close-price semantics, which refers to the meaning of closing prices, without promoting an auction-fill strategy. The original main 15:30 open to bar close remains unchanged, and all fresh cost, stop, and target gates remain in place.